Among all parameters tested, we observed that CCR2 expression (Figure 7B), FLICA+ASC-speck monocyte frequency (Figure 7D), caspase-1 activity (Figure 7E), lipid peroxidation (Figure 7F), intracellular GSH levels (Figure 7H) and spontaneous cytokine release in vitro were all significantly altered in the COVID-19 recovered group versus HCs, indicating that short-term recovery does not afford a return to previous levels for these measurements (Figure 7). The gene discussed is CCR2; the disease is COVID-19.